Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects.

Front Med (Lausanne) · 2021 · PMC8085270 · PMID 33937286

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

In theory, there may be significant clinical utility for risk-stratifying biomarkers to determine which patients may benefit from this procedure ( Figure 5 ).

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.